This HTML5 document contains 200 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1038/
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q89638005
rdf:type
wikibase:Item
schema:description
scientific article published on 10 February 2020 2020年学术文章 2020年學術文章 наукова стаття, опублікована в лютому 2020 vetenskaplig artikel บทความทางวิทยาศาสตร์ 2020 nî lūn-bûn научни чланак wetenschappelijk artikel 2020年学术文章 naučni članak vedecký článok bài báo khoa học artigo científico wissenschaftlicher Artikel 2020年学术文章 2020년 논문 ১০ ফেব্রুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific vědecký článek مقالة علمية نشرت في 10 فبراير 2020 tudományos cikk мақолаи илмӣ article scientifique artikull shkencor articolo scientifico 2020年学术文章 article científic artículo científico publicado en 2020 scientific article published on 10 February 2020 2020年の論文 2020年學術文章 scienca artikolo 2020年學術文章 מאמר מדעי научная статья artigo científico 2020年學術文章 2020年学术文章 tieteellinen artikkeli научни чланак artykuł naukowy artigo científico 2020年学术文章 vitenskapelig artikkel artikel ilmiah scientific article published on 10 February 2020 2020年學術文章 teaduslik artikkel bilimsel makale artikulong pang-agham artículu científicu article scientific სამეცნიერო სტატია videnskabelig artikel udgivet 10. februar 2020 επιστημονικό άρθρο vitskapeleg artikkel 2020 թվականի փետրվարի 10-ին հրատարակված գիտական հոդված научна статия
p:P577
wds:Q89638005-67AEE0A2-7998-4F2F-9E5B-04B8BC3F175D
wdt:P577
2020-02-10T00:00:00Z
p:P2860
wds:Q89638005-8E4CEC50-2402-4E52-BE4D-0AA098EC586D wds:Q89638005-92FAE4E3-9DF2-492E-B9B0-453A0AE0C8E3 wds:Q89638005-86831BF1-44A4-41CF-814B-B6A84F54C930 wds:Q89638005-87574068-D544-46AC-9C77-D133C35E980D wds:Q89638005-88BE5FDE-FF7E-4E91-A13C-8D783F006EC6 wds:Q89638005-8914C7B9-C764-4E52-94B8-6B843053500F wds:Q89638005-7D71A6AB-D2D4-4466-A9D5-0C89E13084D2 wds:Q89638005-80900A3D-B491-4383-9EA5-AB2A6DB14878 wds:Q89638005-757B9D76-3DEA-4FAF-804C-A3D0838BF620 wds:Q89638005-D8D1A36B-D561-4CB0-A3EF-EF0BAE9ED4EB wds:Q89638005-D960FFFD-C78D-45E9-9230-ED7CB9BDFD5D wds:Q89638005-DD6BB9F5-EA9D-4B2D-971B-0687BA6CA2AA wds:Q89638005-C7998CB9-1B67-4139-89BA-3737E8A04857 wds:Q89638005-CFBB4E80-C9AA-4258-907B-594410A8DF61 wds:Q89638005-AD95878D-0AF8-49BB-B92B-837D9D1F6DED wds:Q89638005-B3018602-AD5E-4DE4-86F9-D1CB2E4A06B0 wds:Q89638005-9969EF43-D3FB-4114-B90D-BC468F58905B wds:Q89638005-A7573966-EF6A-48E9-BD6A-C5D7F6D8F251 wds:Q89638005-12DDC638-4F46-42D6-95D4-E915526B813E wds:Q89638005-1DECAF57-1474-4610-97B1-D64E70769177 wds:Q89638005-211CA496-28E3-4B6B-B520-78AECEDA1D3D wds:Q89638005-2220A630-6308-4594-8CAC-4514819C099A wds:Q89638005-0B266399-56D9-44CC-940E-02EA9AED0429 wds:Q89638005-0E49F536-AEF8-4C07-8206-0959417177D1 wds:Q89638005-12623168-39FC-4C9E-A0D1-B4713AE20709 wds:Q89638005-03C0714E-85B8-414D-ADCC-43ED2D87A668 wds:Q89638005-04026616-F8EB-4024-B168-E79CC57AE266 wds:Q89638005-48A439EE-1963-44B8-A024-0B22D411EFF4 wds:Q89638005-50FE6751-737F-4F0C-851E-BE881BA3EB40 wds:Q89638005-3F401920-A30F-4573-9857-F9C71674A9E3 wds:Q89638005-43CECFAA-F94D-4168-91F0-8F5389CA38A9 wds:Q89638005-2EF7082C-C094-4501-A415-335FE1C26272 wds:Q89638005-30F69DF0-8F18-414D-9577-EC060FCA6CE0 wds:Q89638005-2A7CFF54-3DF0-4166-A45B-DE56111F5D3A wds:Q89638005-2B48CD0E-DF00-4D38-8BB5-72D683F65D39 wds:Q89638005-2E6DF348-9101-463E-8BDD-4E3C910EB062 wds:Q89638005-FA50C255-9818-404E-B6CD-7DE857EBF537 wds:Q89638005-FC044385-68DA-4D39-BDEB-8F10E995A8FE wds:Q89638005-FDA37611-C4A5-408E-99E4-0ED14F2A14F1 wds:Q89638005-F1F2ADFE-CC59-48B3-AF3F-E93CE67776EC
wdt:P2860
wd:Q93117354 wd:Q104473870 wd:Q35757381 wd:Q60104303 wd:Q31154742 wd:Q29620856 wd:Q21284194 wd:Q29547403 wd:Q29614489 wd:Q47557998 wd:Q33810971 wd:Q88194392 wd:Q30574894 wd:Q39011183 wd:Q41701241 wd:Q92614138 wd:Q40248504 wd:Q36480617 wd:Q38722200 wd:Q31086305 wd:Q49843823 wd:Q31148615 wd:Q49961734 wd:Q50145619 wd:Q36827209 wd:Q27860966 wd:Q48173597 wd:Q36010386 wd:Q64887861 wd:Q48193977 wd:Q35235365 wd:Q30477923 wd:Q39013253 wd:Q28084527 wd:Q56879989 wd:Q43622503 wd:Q34043398 wd:Q57694776 wd:Q61135541 wd:Q69051965
p:P2093
wds:Q89638005-447E5028-4173-413B-BC0C-0ABF51D8239E wds:Q89638005-460DB8F4-F28B-4F77-A39A-E5CEE99277A3 wds:Q89638005-2E2174A1-133D-473C-A780-2BB6940BD26B wds:Q89638005-1080D9A3-CC3A-4EC5-8426-9CE78E6F4BFE wds:Q89638005-96A7CA51-7E4B-4283-94A6-C621527405D7 wds:Q89638005-C4EEDA67-D2F7-44DC-BF2F-CA41AAE56678 wds:Q89638005-62C3D13F-8A9E-4D5B-9FDE-8B70013FE27C wds:Q89638005-F4E203BE-D05B-4FB2-9C49-91340595CE8B
wdt:P2093
Miranda Payne Isar Nassiri Elise A Mahé Robert A Watson Chelsea A Taylor Sara Danielli Zoe Traill Paul Klenerman
rdfs:label
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
skos:prefLabel
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
schema:name
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
p:P50
wds:Q89638005-B04CD3A2-22F0-480D-B3D1-607AB67E830A wds:Q89638005-D340AB38-75FA-4D41-953C-CB21D60B876F wds:Q89638005-787A6626-3DEC-499A-BDFF-E1F8759044B1 wds:Q89638005-39154ABE-6830-42B5-9245-03BDCA900F67 wds:Q89638005-439F9B97-5561-40AA-A461-1882F8A8C048 wds:Q89638005-4676CE2C-9545-44C9-A75F-4B76A704EDBA wds:Q89638005-0166BEDA-2F29-4C20-91AA-F17ABFD582A4
wdt:P50
wd:Q86815803 wd:Q64711417 wd:Q40602157 wd:Q47502483 wd:Q89638003 wd:Q89413185 wd:Q40247846
p:P1476
wds:Q89638005-F1A1964C-AAC7-4B8A-845D-1C8E30BC8BAE
wdt:P1476
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
p:P304
wds:Q89638005-30267AA9-D1B9-4101-8B61-110BA0D3BBF3
wdt:P304
193-199
p:P31
wds:Q89638005-8D478069-2737-496E-9994-A8B3112D57BC
wdt:P31
wd:Q13442814
p:P921
wds:Q89638005-E329610D-ABBB-43DE-B13C-949B78F7B96A
wdt:P921
wd:Q18975855
p:P698
wds:Q89638005-D267DE16-1BB6-4079-80A0-31B721959312
wdtn:P698
n6:32042196
wdt:P698
32042196
p:P1433
wds:Q89638005-E5427BE6-C28E-4F7A-BA1A-D967CB208FF2
wdt:P1433
wd:Q1633234
p:P433
wds:Q89638005-80889FBB-018D-44EB-8857-A59304D8430D
p:P478
wds:Q89638005-66236015-D974-4D34-BE34-48DC10233CA3
wdt:P433
2
wdt:P478
26
p:P356
wds:Q89638005-8E92752F-BEEF-47FA-B46A-167E677D6878
wdtn:P356
n9:S41591-019-0734-6
wdt:P356
10.1038/S41591-019-0734-6
p:P4510
wds:Q89638005-A353D3CC-4A66-4A86-AA53-BAA135C4A0ED
wdt:P4510
wd:Q112281656